AAC HOLDINGS, INC. (NYSE:AAC) Files An 8-K Regulation FD Disclosure
Item 7.01.Regulation FD Disclosure.

On November 21, 2018, AAC Holdings, Inc. (the “Company”), certain of its subsidiaries, and certain of its current and former officers entered into a settlement with plaintiffs to settle the litigation >

Also on November 21, 2018, the Company entered into a settlement with its former officer and director, Jerrod N. Menz (“Menz”). In exchange for Menz releasing his claim for indemnification in the Smith Litigation, the Company has agreed to release Menz from his agreement to contribute 300,000 shares to the settlement of the securities class action lawsuit (Kasper v. AAC Holdings, Inc., et al., Case No. 3:15-cv-923, United States District Court for the Middle District of Tennessee) that was finally settled on June 11, 2018.

About AAC HOLDINGS, INC. (NYSE:AAC)

AAC Holdings, Inc. is a provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1,139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers. In addition, the Company focuses on expanding The Oxford Centre facility. As of June 30, 2016, the Company’s capacity at its Forterus treatment facility was 14 beds. The Company is engaged in deploying research-based treatment programs with structured curricula for detoxification, residential treatment, partial hospitalization and intensive outpatient care. The Company is also an Internet marketer in the addiction treatment industry.